PharmaDossierIndependent biopharma information, guidance, and source-cited analysis.

PHARMApharmadossier

Topic

ASP

Average Sales Price methodology, quarterly ASP pricing files, WAC-based reimbursement, and Part B drug payment limits.

5 articles·Lives underPricing & Access Policy·Last updated 2026-09-09

Pricing & Access· September 9, 2026 · 16 min read

Revised CMS ASP Files: Reconcile the Quarter, Version, and HCPCS Code

By Ran Chen#ASP #HCPCS

Policy· August 23, 2026 · 16 min read

CMS-10110 Turns Quarterly ASP Into a Part B MFP Compliance Feed: Comments Oct 20

By Ran Chen#CMS #ASP #Medicare Part B

Pricing & Access· August 22, 2026 · 17 min read

CMS's 340B OPPS Cut: ASP Minus 33.4%, the 2026 Survey, and August 31 Clock

By Ran Chen#340B #CMS #Medicare Part B

Pricing & Access· May 22, 2026 · 12 min read

ASP lag after launch: why buy-and-bill economics can break in the first quarters

By Ran Chen#Medicare Part B #ASP #Buy and Bill

Pricing & Access· May 22, 2026 · 9 min read

J-code timing and interim billing risk for new buy-and-bill biologics

By Ran Chen#Medicare Part B #HCPCS #J-Code